Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Talk Digital Health Technologies track

Digital Health Technology (DHT)-Derived Physical Activity and Performance in Cancer Cachexia

Tue, Feb 4, 2025 · 3:25–3:55 PM EST Rosen Shingle Creek

About this session

Cachexia is prevalent across cancer types and results in weight loss, muscle wasting, reduced physical activity (PA), and increased mortality. DHTs provide passive, unbiased, patient-focused, and quantitative measures of continuous PA/function. We will share evidence on the importance of PA to patients, and what a meaningful change is in cancer patients with cachexia. Moreover, we will discuss the use of the DHT-derived PA measures to assess function and support clinical trials.

Speaker